Fetching the paper…
Reading the bibliography…
The pharmaceutical industry faces unprecedented challenges in drug discovery, with traditional approaches struggling to meet modern therapeutic development demands.
Computational drug design: a guide for computational and medicinal chemists
David C Young · 2009
Earlier work this paper cites.
The strategies and politics of successful design, make, test, and analyze (dmta) cycles in lead generation
Steven S Wesolowski and Dean G Brown · 2016
Earlier work this paper cites.
Computational methods in drug discovery
Sumudu P Leelananda and Steffen Lindert · 2016
Earlier work this paper cites.
Computational chemistry in drug lead discovery and design
Claudio N Cavasotto, María Gabriela Aucar, and Natalia S Adler · 2019
Earlier work this paper cites.
Deep learning methods for small molecule drug discovery: A survey
Wenhao Hu, Yingying Liu, Xuanyu Chen, Wenhao Chai, Hangyue Chen, Hongwei Wang, and Gaoang Wang · 2023
Earlier work this paper cites.
A call for caution in the era of ai-accelerated materials science
Kangming Li, Edward Kim, Yao Fehlis, Daniel Persaud, Brian DeCost, Michael Greenwood, and Jason Hattrick-Simpers · 2023
Earlier work this paper cites.
Overcoming dmta cycle challenges: A unified ai-driven system for efficient drug design
Matthew Medcalf, Varsha Jain, Stefani Gamboa, Brian Atwood, Maoussi Lhuillier-Akakpo, Victoire Cachoux, and Quentin Perron · 2024
Earlier work this paper cites.
Augmenting dmta using predictive ai modelling at astrazeneca
Gian Marco Ghiandoni, Emma Evertsson, David J Riley, Christian Tyrchan, and Prakash Chandra Rathi · 2024
Cited alongside, same era.
Current status of computational approaches for small molecule drug discovery, 2024
Weijun Xu · 2024
Cited alongside, same era.
Artificial intelligence in drug development
Kang Zhang, Xin Yang, Yifei Wang, Yunfang Yu, Niu Huang, Gen Li, Xiaokun Li, Joseph C Wu, and Shengyong Yang · 2025
Cited alongside, same era.
Academic drug discovery units in the uk: Progress and challenges
Michael M Hopkins, Jorge Mestre-Ferrandiz, Phillipa Crane, and Michael O’Neill · 2025
Cited alongside, same era.
Harnessing network pharmacology in drug discovery: an integrated approach
Chandra Prakash Joshi, Ashish Baldi, Neeraj Kumar, and Joohee Pradhan · 2025
Cited alongside, same era.
Identifying rna-small molecule binding sites using geometric deep learning with language models
Uncovering bottlenecks and optimizing scientific lab workflows with cycle time reduction agents, 2025
Yao Fehlis · 2025
Closest in time.
The role of agentic ai in shaping a smart future: A systematic review
Soodeh Hosseini and Hossein Seilani · 2025
Closest in time.
Industrial agentic ai and generative modeling in complex systems
Mohammad Reza Boskabadi, Yudong Cao, Behnam Khadem, William Clements, Z Nevin Gerek, Eric Reuthe, Abhishek Sivaram, Christopher J Savoie, and Seyed Soheil Mansouri · 2025
Closest in time.
From prompt to platform: an agentic ai workflow for healthcare simulation scenario design
Federico Lorenzo Barra, Giovanna Rodella, Alessandro Costa, Antonio Scalogna, Luca Carenzo, Alice Monzani, and Francesco Della Corte · 2025
Closest in time.
Comprehensive review of artificial general intelligence agi, agentic ai and genai: Current trends and future directions
Satyadhar Joshi · 2025
Closest in time.
alphaXiv searches the wider corpus for related work and actual follow-ups.
alphaXiv is searching for related work…
Weimin Zhu, Xiaohan Ding, Hong-Bin Shen, and Xiaoyong Pan · 2025
Cited alongside, same era.
Accelerating drug discovery with artificial: a whole-lab orchestration and scheduling system for self-driving labs, 2025
Yao Fehlis, Paul Mandel, Charles Crain, Betty Liu, and David Fuller · 2025
Closest in time.